Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion
CVD Risk in Prostate Cancer: Future Directions in Care
Closing out their discussion on cardiovascular disease in prostate cancer, experts share their hopes for future evolution of the treatment landscape.
Multidisciplinary Care in Prostate Cancer and CVD Management
Shared insight on the value of multidisciplinary care and its current state in cardiovascular disease and prostate cancer.
CVD Risk in Prostate Cancer: Quality Measures and Coverage Policy
Maria Lopes, MD, MS, elucidates the potential for quality measures and coverage policies to incorporate cardiovascular disease (CVD) and improve outcomes in prostate cancer.
What Evidence Is Needed to Further Define CVD Risk in Prostate Cancer?
Experts share insight on the need for clinical or real-world evidence to further solidify cardiovascular disease risk as an actionable factor in prostate cancer.
Factors in Evaluating Therapy for Prostate Cancer
Expert perspectives on factors that inform prostate cancer therapy selection while keeping cardiovascular disease in mind.
CVD in Prostate Cancer: Risk-Bearing Practices and Alternative Payment Models
Continuing their discussion on cost of care in prostate cancer, experts reflect on how cardiovascular disease impacts risk-bearing practices and alternative payment models.
Impact of CVD Risk on Cost of Care in Prostate Cancer
Shared insight on the impact that cardiovascular disease has on cost of care in prostate cancer.
Prostate Cancer and CVD: Professional Society Guidelines
Experts consider available professional society guidelines on prostate cancer and cardiovascular disease management.
Prostate Cancer: Identifying Patients at Risk for CVD
A brief review of factors that may put patients with prostate cancer at increased risk for developing cardiovascular disease.
CVD Risk Associated With ADT in Prostate Cancer
Focusing on available agents in prostate cancer, experts consider how androgen deprivation therapy impacts risk of cardiovascular disease.
An Overview of the Prostate Cancer Treatment Landscape
A comprehensive review of the therapeutic classes available for patients with prostate cancer.
Correlation Between Prostate Cancer and Cardiovascular Disease
Shared insight on the correlation between prostate cancer and cardiovascular disease, with a focus on the attributes that increase a patient’s risk.
Prostate Cancer’s Impact on Economy and Life
A broad look at the economic burden of prostate cancer and outlook in regard to survival within the current treatment landscape.
Understanding the Clinical Burden of Prostate Cancer
Expert perspectives on prostate cancer with deference to clinical presentations, diagnosis, and prognosis.
2 Clarke Drive Cranbury, NJ 08512